Inpatient diabetes: Review of data from the cardiac care unit

Endocrine Practice

Volumn 12, Issue SUPPL. 3, 2006, Pages 27-34

  Hirsch, Irl B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HUMAN INSULIN; HYPERGLYCEMIC AGENT; INSULIN; ISOPHANE INSULIN; POTASSIUM; REVIPARIN;

ACUTE HEART INFARCTION; CLINICAL STUDY; CONFERENCE PAPER; CRITICALLY ILL PATIENT; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DRUG INFUSION; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MORTALITY; MULTIPLE CYCLE TREATMENT; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33845702757     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.12.s3.27     Document Type: Conference Paper

References (23)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
2. National Diabetes Fact Sheet, United States 2005. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf. Accessed January 22, 2005.
3. Ishihara M, Kojima S, Sakamoto T, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005;150:814-820.
4. Norhammer A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
5. Timmer JR, van der Horst ICC, Ottervanger JP, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004;148:399-404.
6. Esposito K, Nappo F, Marfella H, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067-2072.
7. Malmberg K for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
8. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
9. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795-2804.
10. Schiekofer S, Andrassy M, Chen J, et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaβ in PBMCs. Diabetes. 2003;52:621-633.
11. Mehta SR, Yusuf S, Diaz R, et al (The CREATE-ECLA Group Investigators). Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA. 2005;293:437-446.
12. Hirsch IB. Effect of insulin therapy on nonglycemic variables during acute illness. Endocr Pract. 2004;10(Suppl 2):63-70.
13. Krljanac G, Vasiljevic Z, Radovanovic M, et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol. 2005;96:1053-1058.
14. van der Horst IC, Zijlstra F, van't Hof AW, et al (Zwolle Infarct Study Group). Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol. 2003;42:784-791.
15. Ceriello A, Hanefeld M, Leiter L, et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004;164:2090-2095.
16. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
17. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078-3086.
18. Chaudhuri A, Janicke D, Wilson MF, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation. 2004;109:849-854.
19. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low manose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082-1088.
20. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004;79:992-1000.
21. Golovchenko I, Goalstone ML, Watson P, et al. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaβ induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000;87:746-752.
22. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabotic control. Endocr Pract. 2004;10(Suppl 2):4-9.
23. Clement S, Braithwaite S, Magee M, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.